Remdesivir Shortens Time to Recovery in COVID19 (ACTT-1), CRP-Guided Antibiotics for Gram Negative Bacteremia, NT-pro-BNP in Syncope

Last Week in Medicine

Content provided by Stephen Jenkins, MD, Austin Rupp, MD, Stephen Jenkins, MD, and Austin Rupp. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Stephen Jenkins, MD, Austin Rupp, MD, Stephen Jenkins, MD, and Austin Rupp or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

4y ago 36:26

MP3•Episode home

We're back with another episode. We cover the latest highlights in COVID, including the exciting new results on remdesivir from the ACTT-1 trial. We also talk about whether you can use CRP to guide duration of antibiotic therapy in patients with gram negative bacteremia, and whether NT-pro-BNP can help you risk-stratify patients with syncope. Check it out!
Remdesivir Shortens Time to Recovery in COVID19 (ACTT-1)
CRP Guided Antibiotics or 7 Days vs 14 Days for Gram Negative Bacteremia
NT-pro-BNP in Syncope
Music from https://filmmusic.io
"Sneaky Snitch" by Kevin MacLeod (https://incompetech.com)
License: CC BY (http://creativecommons.org/licenses/by/4.0/)

57 episodes

#Fitness #Medicine #Stephen Jenkins, MD, Austin Rupp, MD #Austin Rupp #Internal Medicine #Medical Journals #Research Articles #Guidelines #Alternative Health #Mental Health